Vladimir Torchilin is University Distinguished Professor of pharmaceutical sciences and the Director of the Center for Pharmaceutical Biotechnology and Nanomedicine at Northeastern University, USA. His research interests include drug delivery and targeting, nanomedicine, multifunctional and stimuli-sensitive pharmaceutical nanocarriers, biomedical polymers, experimental cancer therapy, cancer immunology, and novel imaging agents. He has published more than 450 original papers, more than 150 reviews and book chapters, 12 books, and holds more than 40 patents. Google Scholar gives more than 66,000 citations of his work with H-index of 114. Prof. Torchilin is editor-in-chief of Drug Delivery and Current Drug Discovery Technologies and is on the editorial boards of several leading journals in the field, including Journal of Controlled Release (review editor), Bioconjugate Chemistry, Advanced Drug Delivery Reviews, European Journal of Pharmaceutics and Biopharmaceutics, Journal of Drug Targeting, Molecular Pharmaceutics, and Journal of Biomedical Nanotechnology. He is also a Full Member of the European Academy of Sciences and Fellow of the American Institute of Medical and Biological Engineering, American Association of Pharmaceutical Scientists (AAPS), and the Controlled Release Society. He is a recipient of the 1982 Lenin Prize in Science and Technology (the highest scientific award in the former USSR), the 2005 Research Achievements in Pharmaceutics and Drug Delivery Award from the AAPS, the 2007 Research Achievements Award from the Pharmaceutical Sciences World Congress, the 2009 AAPS Journal Award, the 2009 International Journal of Nanomedicine Distinguished Scientist Award, the 2010 Controlled Release Society Founders Award, the 2012 Life Time Achievements Award from the Journal of Drug Targeting, the 2012 Alec Bangham Life Time Award, and the 2013 Blaise Pascal Medal for Biomedicine from the European Academy of Sciences.
